Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor

Wound Repair and Regeneration

Volumn 12, Issue 2, 2004, Pages 252-259

  Akita, Sadanori ^a   Fukui, Masashi ^a   Nakagawa, Hiroshi ^a   Fujii, Tohru ^a   Akino, Kozo ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASCORBIC ACID 2 PHOSPHATE; CYTOKINE; DEXAMETHASONE; GELATIN SPONGE; GLYCEROL 2 PHOSPHATE; OSTEOCALCIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADD ON THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MODEL; DUAL ENERGY X RAY ABSORPTIOMETRY; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; FRACTURE HEALING; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYME CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SKULL DEFECT; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ANIMALS; BONE DENSITY; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOCALCIN; RATS; RATS, NUDE; SKULL; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS;

EID: 1942468869     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1067-1927.2004.012118.x     Document Type: Article

References (20)

1. Lemperle SM, Calhoun CJ, Curran RW, Holmes RE. Bony healing of large cranial and mandibular defects protected from soft-tissue interposition: a comparative study of spontaneous bone regeneration, osteoconduction, and cancellous autografting in dogs. Plast Reconstr Surg 1998;101:660-72.
2. Ono I, Takeshita T, Satou M, Sasaki T, Matsumoto M, Kodama N. Treatment of large complex cranial bone defects by using hydroxyapatite ceramic implants. Plast Reconstr Surg 1999;104:339-49.
3. Mardas N, Kostopoulos L, Karring T. Bone and suture regeneration in calvarial defects by e-PTFE-membranes and demineralized bone matrix and the impact on calvarial growth: an experimental study in the rat. J Craniofac Surg 2002;13:453-62.
4. Xie XT, Qiu WL, Yuan WH, Wang ZH. Experimental study of radiation effect on the mandibular microvasculature of the guinea pig. Chin J Dent Res 1998;1:46-51.
5. Hopper RA, Zhang JR, Fourasier VL, Morova-Protzner I, Protzner KF, Pang CY, Forrest CR. Effect of isolation of periosteum and dura on the healing of rabbit calvarial inlay bone grafts. Plast Reconstr Surg 2001;107:454-62.
6. Gosain AK, Song L, Yu P, Mehrara BJ, Maeda CY, Gold LI, Longaker MT. Quantitative assessment of cranial defect healing and correlation with the expression of TGF-beta. J Craniofac Surg 2001;12:401-4.
7. Sato K, Urist MR. Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs. Clin Orthop 1985;197:301-11.
8. Kobayashi K, Agrawal K, Jackson IT, Vega JB. The effect of insulin-like growth factor 1 on craniofacial bone healing. Plast Reconstr Surg 1996;97:1129-35.
9. Dazai S, Akita S, Hirano A, Rashid MA, Naito S, Akino K, Fujii T. Leukemia inhibitory factor enhances bone formation in calvarial bone defect. J Craniofac Surg 2000;11:513-20.
10. Lee FY, Storer S, Hazan EJ, Gebhardt MC, Mankin HJ. Repair of bone allograft fracture using bone morphogenetic protein-2. Clin Orthop 2002;397:119-26.
11. Yoshida K, Bessho K, Fujimura K, Kusumoto K, Ogawa Y, Tani Y, Iizuka T. Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study. J Craniomaxillofac Surg 1998;26:112-5.
12. Wang C, Mao T, Zhao M. An experimental study on the effect of xenogeneic bone combined with human recombinant bone morphogenetic protein-2. Zhonghua Kou Qiang Yi Xue Za Zhi 1997;32:360-2.
13. Power RA, Iwaniec UT, Wronski TJ. Changes in gene expression associated with the bone anabolic effects of basic fibroblast growth factor in aged ovariectomized rats. Bone 2002;31:143-8.
14. Rice DP, Aberg T, Chan Y, Tang Z, Kettunen PJ, Pakarinen L, Maxson RE, Thesloff I. Integration of FGF and TWIST in calvarial bone and suture development. Development 2000;127:1845-55.
15. Devine SM. Mesenchymal stem cells: will they have a role in the clinic? J Cell Biochem Suppl Supplement 2002;38:73-9.
16. Akita S, Hirano A, Fujii T. Identification of IGF-I in the calvarial suture of young rats: histochemical analysis of the cranial sagittal sutures in a hyperthyroid rat model. Plast Reconstr Surg 1996;97:1-12.
17. Greenwald JA, Mehrara BJ, Spector JA, Warren SM, Fagenholz PJ, Smith LE, Bouletreau PJ, Crisera FE, Ueno H, Longaker MT. In vivo modulation of FGF biological activity alters cranial suture fate. Am J Pathol 2001;158:441-52.
18. Lou J, Tu Y, Li S, Manske PR. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochem Biophys Res Commun 2000;268:757-62.
19. Suzuki A, Palmer G, Bonjour JP, Caverzasio J. Stimulation of sodium-dependent phosphate transport and signaling mechanisms induced by basic fibroblast growth factor in MC3T3-E1 osteoblast-like cells. J Bone Miner Res 2000;15:95-102.
20. Krebsbach PH, Mankani MH, Satomura K, Kuznetsov SA, Robey PG. Repair of craniotomy defects using bone marrow stromal cells. Transplantation 1998;66:1272-8.